With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Asia, Pacifi c Rim countries.
The latest business developments from across Asia by Heather Hobbs To appear in our next issue, send your Business and Financial News stories to
heather@intlabmate.com
This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
GW Pharmaceuticals and the Government of New South Wales Announce Clinical Trial for Children with Epilepsy
trials in Australia for both Epidiolex and our earlier stage pipeline product CBDV.”
“This confi rms NSW’s position as a world leader in cannabinoid research and demonstrates the determination of our Government to ensure we secure these groundbreaking trials,” stated NSW Premier Mike Baird. “Our research and development is driven by compassion for those suffering so we hope that these initiatives will bring relief to many children and their loved ones.”
NSW Premier Mike Baird GW’s CEO Justin Gover
GW Pharmaceuticals plc and the Government of New South Wales (NSW) Australia, have signed a Memorandum of Understanding (MOU,) to progress a research program for Epidiolex® (cannabidiol or CBD) and cannabidivarin (CBDV) in children with severe, drug resistant childhood epilepsy.
“GW is pleased to have been able to respond to the needs of the New South Wales government and its citizens by establishing this research program for cannabinoid-based medicines in children with treatment resistant epilepsy,” said Justin Gover, GW’s Chief Executive Offi cer. “As part of this research partnership, GW expects to advance clinical
The NSW Government is providing $3.5 million to the Sydney Children’s Hospitals Network to lead the Phase 2 clinical trial of CBDV in children, which is expected to commence in 2016. The agreement also delivers a compassionate access program for Epidiolex for a small number of children who are too sick to participate in a clinical trial, due to the unrelenting nature of their epilepsy. Like CBD, CBDV does not produce the psychoactive effects associated with herbal cannabis. The package is supported through the NSW Government’s $21 million commitment to support medicinal cannabis reforms.
36772pr@reply-direct.com
TFS Celebrates Opening of GMP Facility
Thermo Fisher Scientifi c has announced the offi cial opening of its new GMP facility to meet the growing demand for clinical supply services in Singapore. Located in Toh Guan Road, Jurong East, the new facility is nearly 70,000 ft2 (6,500m2), more than 60% larger than the previous site established in 2001. With double the cold chain capacity it will provide a one-stop service for clinical supplies − from GMP storage, local labelling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to returns management. Improved technologies and operational tools, include a larger storage system for its clinical supplies, a new climatic control energy consumption system that reduces the facility’s carbon footprint and an overall building monitoring system that provides staff with timely updates on the facility’s conditions.
Presentation Highlights Importance of Sample Preparation
This fl agship summit was the 10th since India introduced its Food Safety & Standards Act in 2006; its importance is notable since the Food & Beverage industry has now become the largest employment sector in India, having overtaken Textiles. Other speakers included experts from the Food Safety & Standards Authority of India (FSSAI), Ministry of Food Processing, Ministry of Health and Family Welfare, as well as other leading representatives from the food manufacturing, safety and quality industry.
In his presentation, Stuart Ray discussed the importance of quality sample preparation for accurate food safety analyses. He also provided an overview of international standards and testing methods, commenting on their potential impact and relevance to the Indian domestic and export market.
Stuart Ray speaking at the 10th National Food Safety and Quality Summit, New Dehli
Stuart Ray, Technical Director at Seward Ltd, manufacturers of laboratory paddle blenders and accessories used in sample preparation for microbiological analysis, recently presented a paper at a prestigious food safety conference in New Delhi. The 10th National Food Safety and Quality Summit, organised by the Confederation of Indian Industry (CII) focused on ‘Integrating Global Perspectives on Food Safety and Quality for Enhanced Consumer Safety’.
“In recent years we have experienced an increasing demand in India for our sample preparation products; this is not surprising given the ongoing growth in its food export market,” said Stuart Ray, Seward Ltd. “With the introduction of India’s new food safety legislation and drive towards aligning all standards with Codex Alimentaris, we can fully support food manufacturers in this drive due to our global experience and understanding in food sample preparation for microbiology.”
37549pr@reply-direct.com
“Asia Pacifi c continues to be our fastest-growing market and a central contributor to our growth,” said Leon Wyszkowski, Thermo Fisher’s Vice President of Clinical Services for North America and facility network. “For nearly 15 years, Singapore has been the central hub for our Asia- Pacifi c operations, due to its strategic location. With the opening of our larger and well-equipped facility, we aim to continue to build on our Singapore facility further and on the expertise of our local team, to strengthen our regional and global presence in the clinical supplies industry.”
37550pr@reply-direct.com
Waters Opens Subsidiaries in Malaysia
A new offi ce in Kuala Lumpur, Malaysia is now handling all sales, service, support and distribution of Waters and TA Instrument technologies direct to customers. “Due to the dynamic development of the analytical instrument business in Malaysia, Waters is delighted to extend our support to our expanding customer base by establishing direct in-country operations. Speaking on behalf of all new Waters employees in Malaysia, we are extremely excited to take our sales and service capabilities to new levels,” said Mathieu Laouenan, General Manager of South East Asia & Australia, Waters Division. “We would also like to thank our valued long-term business partner, Research Instruments Sdn. Bhd for their full support and professional help in planning this transition,” continued Mr Laouenan.
To manage the newly created subsidiary Waters Analytical Instruments Sdn Bhd, the company also announced the appointment of Krishna Kodoth as General Manager, Malaysia, focusing on Waters branded technologies and services.
With 11 years in sales and management positions, Mrs Jasmine Keller Ooi has been appointed the TA Instruments Country Manager with responsibility for both Singapore and Malaysia.
Does your company sell or wish to sell laboratory products and services to the economies of Asia? Are you looking for local distributors and agents to represent you?
If so, why not advertise your products in our market-leading journal International Labmate. Email:
info@intlabmate.com
37548pr@reply-direct.com
Business
Opportunities Asia
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
